drugset / Trial / NCT06925997
Metabolic Effects of Endogenous Bile Acids After Gastric Bypass Surgery
NaSingle-groupOpen-labelBasic science
Summary
Non-randomized, open-label, parallel-group clinical study evaluating the effects of endogenous bile acids on changes in plasma fibroblast growth factor-19 (FGF-19) and glucose metabolism by extended depletion of circulating bile acids using colesevelam as an experimental tool in subjects operated with gastric by-pass (RYGB).
Timeline
- Start
- 2024-05-02
- Primary completion
- 2027-12
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Colesevelam | Other / unclassified | 3.75 g | — |